CSIMarket
 


Inhibitor Therapeutics Inc   (HPPI)
Other Ticker:  
 
 

HPPI's Income Taxes Growth by Quarter and Year

Inhibitor Therapeutics Inc 's Income Taxes results by quarter and year




HPPI Income Taxes (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.06 0.00 0.00
III Quarter September - 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.06 0.00 0.00



HPPI Income Taxes second quarter 2023 Y/Y Growth Comment
Inhibitor Therapeutics Inc in the second quarter 2023 recorded Provisions for income taxes of $ 0.00 millions.

According to the results reported in the second quarter 2023, Inhibitor Therapeutics Inc achieved the best Income Taxes growth in Major Pharmaceutical Preparations industry. While Inhibitor Therapeutics Inc ' s Income Taxes no change of % ranks overall at the positon no. in the second quarter 2023.

Explain Operating Income growth


HPPI Income Taxes ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Inhibitor Therapeutics Inc 's second quarter 2023 Income Taxes $ 0.00 millions HPPI's Income Statement
Inhibitor Therapeutics Inc 's second quarter 2022 Income Taxes $ 0.00 millions Quarterly HPPI's Income Statement
New: More HPPI's historic Income Taxes Growth >>


HPPI Income Taxes (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income Taxes second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income Taxes Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income Taxes second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income Taxes Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income Taxes by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Inhibitor Therapeutics Inc 's Q/Q Income Taxes Growth


Income Taxes Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HPPI's II. Quarter Q/Q Income Taxes Comment


Income Taxes Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income Taxes Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income Taxes Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HPPI's II. Quarter Q/Q Income Taxes Comment


Inhibitor Therapeutics Inc 's 12 Months Income Taxes Growth Year on Year


Income Taxes TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Income Taxes 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Income Taxes Growth (TTM) - - - - -
Year on Year Income Taxes Growth Overall Ranking # # # # #
Seqeuential Income Taxes Change (TTM) - - - - -
Seq. Income Taxes Growth (TTM) Overall Ranking # # # # #




Cumulative Income Taxes growth Comment
In the Jun 30 2023 period, Inhibitor Therapeutics Inc 's cumulative trailing twelve month Income Taxes remained unchanged compare to the same period a year ago.

Inhibitor Therapeutics Inc achieved highest trailing twelve month year on year Income Taxes growth. While overall Income Taxes growth ranking, remained unchanged compare to the previous quarter at no. .

Income Taxes TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income Taxes TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income Taxes TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income Taxes TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income Taxes growth Comment
In the Jun 30 2023 period, Inhibitor Therapeutics Inc 's cumulative trailing twelve month Income Taxes remained unchanged compare to the same period a year ago.

Inhibitor Therapeutics Inc achieved highest trailing twelve month year on year Income Taxes growth. While overall Income Taxes growth ranking, remained unchanged compare to the previous quarter at no. .

Income Taxes TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income Taxes TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income Taxes TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income Taxes TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income Taxes Growth
Major Pharmaceutical Preparations Industry Income Taxes Growth Trends and Statistics
Healthcare Sector Income Taxes Growth Statistics
Income Taxes Growth Trends for overall market
HPPI's Income Taxes Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income Taxes Growth
Lowest Ranking Income Taxes Growth
Income Taxes Growth for HPPI's Competitors
Income Taxes Growth for Inhibitor Therapeutics Inc 's Suppliers
Income Taxes Growth for HPPI's Customers

You may also want to know
HPPI's Annual Growth Rates HPPI's Profitability Ratios HPPI's Asset Turnover Ratio HPPI's Dividend Growth
HPPI's Roe HPPI's Valuation Ratios HPPI's Financial Strength Ratios HPPI's Dividend Payout Ratio
HPPI's Roa HPPI's Inventory Turnover Ratio HPPI's Growth Rates HPPI's Dividend Comparisons



Companies with similar Income Taxes no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Income Taxes for the quarter ending Jun 30 2023
U S Physical Therapy Inc-0.19%$ -0.189 millions
Prestige Consumer Healthcare Inc -1.20%$ -1.203 millions
Beigene ltd -1.37%$ -1.370 millions
Align Technology inc -1.70%$ -1.700 millions
Quest Diagnostics Inc-2.60%$ -2.597 millions
Transmedics Group Inc -4.55%$ -4.545 millions
Airsculpt Technologies Inc -6.92%$ -6.919 millions
Tenet Healthcare Corp-6.98%$ -6.977 millions
Reviva Pharmaceuticals Holdings Inc -7.01%$ -7.008 millions
Zynex inc -7.60%$ -7.597 millions
Viatris Inc -8.49%$ -8.488 millions
Sight Sciences Inc -11.11%$ -11.111 millions
Utah Medical Products Inc-11.31%$ -11.314 millions
Vanda Pharmaceuticals Inc -11.84%$ -11.842 millions
Pediatrix Medical Group Inc -13.52%$ -13.518 millions
Biocryst Pharmaceuticals Inc -13.55%$ -13.551 millions
Chemed Corporation-13.65%$ -13.654 millions
Merit Medical Systems Inc-13.84%$ -13.844 millions
Acadia Healthcare Company Inc -17.47%$ -17.472 millions
Evolus Inc -17.86%$ -17.857 millions
Bionano Genomics Inc -19.51%$ -19.512 millions
Ironwood Pharmaceuticals inc -20.65%$ -20.647 millions
Carlisle Companies Incorporated-20.80%$ -20.796 millions
National Research Corporation-20.82%$ -20.824 millions
West Pharmaceutical Services Inc -21.27%$ -21.267 millions
Intuitive Surgical Inc -21.54%$ -21.543 millions
Abbott Laboratories-21.86%$ -21.856 millions
Spyre Therapeutics Inc -22.22%$ -22.222 millions
Davita Inc -23.99%$ -23.994 millions
Artivion Inc -24.40%$ -24.400 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com